Skip to main content
Top
Published in: Breast Cancer 2/2004

01-04-2004 | Original Article

A phase II study of S-1 in patients with metastatic breast cancer — A Japanese trial by the S-1 cooperative study group, breast cancer working group

Authors: Toshiaki Saeki, Shigemitsu Takashima, Muneaki Sano, Noboru Horikoshi, Shigeto Miura, Satoru Shimizu, Ken Morimoto, Morihiko Kimura, Hideaki Aoyama, Jun Ota, Shinzaburo Noguchi, Tetsuo Taguchi

Published in: Breast Cancer | Issue 2/2004

Login to get access
Metadata
Title
A phase II study of S-1 in patients with metastatic breast cancer — A Japanese trial by the S-1 cooperative study group, breast cancer working group
Authors
Toshiaki Saeki
Shigemitsu Takashima
Muneaki Sano
Noboru Horikoshi
Shigeto Miura
Satoru Shimizu
Ken Morimoto
Morihiko Kimura
Hideaki Aoyama
Jun Ota
Shinzaburo Noguchi
Tetsuo Taguchi
Publication date
01-04-2004
Publisher
Springer-Verlag
Published in
Breast Cancer / Issue 2/2004
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/BF02968301

Other articles of this Issue 2/2004

Breast Cancer 2/2004 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine